Cargando…
Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition
Despite improvements in cancer treatments resulting in higher survival rates, the proliferation and metastasis of tumors still raise new questions in cancer therapy. Therefore, new drugs and strategies are still needed. Midazolam (MDZ) is a common sedative drug acting through the γ-aminobutyric acid...
Autores principales: | Lu, Hsin-Ling, Wu, King-Chuen, Chen, Char-Wen, Weng, Hong-Kai, Huang, Bu-Miin, Lin, Ting-Yu, Liu, Ming-Hsin, So, Edmund-Cheung, Lin, Ruey-Mo, Wang, Yang-Kao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703822/ https://www.ncbi.nlm.nih.gov/pubmed/34947927 http://dx.doi.org/10.3390/life11121396 |
Ejemplares similares
-
Midazolam inhibits chondrogenesis via peripheral benzodiazepine receptor in human mesenchymal stem cells
por: Chen, Yung‐Ching, et al.
Publicado: (2018) -
Midazolam induces apoptosis in MA-10 mouse Leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway
por: So, Edmund Cheung, et al.
Publicado: (2014) -
Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
por: Ho, Nguyen-Tuong, et al.
Publicado: (2022) -
Midazolam’s Effects on Delayed-Rectifier K(+) Current and Intermediate-Conductance Ca(2+)-Activated K(+) Channel in Jurkat T-lymphocytes
por: Foo, Ning-Ping, et al.
Publicado: (2021) -
Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells
por: Kang, Fu-Chi, et al.
Publicado: (2018)